Photo credit: Barbara Ries for UCSF, Jaquell Chandler, and OHSU/Christine Torres Hicks The California Institute for Regenerative Medicine (CIRM), California’s Stem Cell Agency and the world’s largest institution dedicated to regenerative medicine reached a milestone when it approved funding for its 100th clinical trial. At the February Independent Citizens’ Oversight Committee (ICOC) meeting, the board … Continue reading CIRM celebrates landmark 100+ clinical trial awards
CIRM Awards $21.3 Million to Foster Collaboration Through Shared Labs
Shared resources, including state-of-the art lab equipment and expertise, foster collaboration (above). Photo courtesy of UCLA Broad Stem Cell Research Center. The California Institute for Regenerative Medicine (CIRM) has approved awarding $21.3 million to create a network of Shared Resources Laboratories (SRLs) for Stem Cell-Based Modeling. The SRLs are an important component of CIRM’s Infrastructure … Continue reading CIRM Awards $21.3 Million to Foster Collaboration Through Shared Labs
CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $56 million to fund various clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers. The awards will support seven projects—five clinical trials and two preclinical projects—in the Agency’s clinical program which provides funding for … Continue reading CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers
Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial
Photo Courtesy of Neurona Therapeutics/Curtis Myers Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, recently announced the successful completion of a $120 million financing. Neurona’s financial success is an encouraging sign for the stem cell and gene therapy sector, highlighting partnerships with investors and public organizations … Continue reading Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial
CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
Stock image of a dual tone brain by Getty Images South San Francisco, CA, Jan. 29, 2024 - The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded almost $26 million to fund various clinical research — from treating bipolar depression to advancing a therapy for spinal cord injury. … Continue reading CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
CIRM Announces Interim CEO
Vito Imbasciani, PhD, MD, Board Chair and Jonathan Thomas, PhD, JD, Interim President and CEO South San Francisco, CA, Dec. 15, 2023 - The Independent Citizens Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine (CIRM), named Jonathan Thomas, PhD, JD as CIRM’s Interim President and CEO at the Dec. 14 meeting. … Continue reading CIRM Announces Interim CEO
Statement from CIRM on the FDA Approval of Gene Therapies for Sickle Cell Disease
The California Institute for Regenerative Medicine (CIRM) applauds and acknowledges the historic significance of the Food and Drug Administration (FDA) approval of Vertex and CRISPR Therapeutics’ CRISPR-based gene therapy (Casgevy) for sickle cell disease. As the first regulatory authorization of a CRISPR-based gene editing therapy in the world, this brings forth a new era of treatment options … Continue reading Statement from CIRM on the FDA Approval of Gene Therapies for Sickle Cell Disease
CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
Diana Farmer, MD and Aijun Wang, PhD. Photo courtesy UC Davis Health South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, has awarded $17.5 million to fund clinical-stage research projects aimed at advancing stem cell and gene therapy treatments for a variety of conditions … Continue reading CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
CIRM Joins World AIDS Day Campaign, Commits $104 Million for HIV Research
John A. Zaia, MD, of Beckman Research Institute of City of Hope This year marks the 35th commemoration of World AIDS Day, a global event that aims to end human immunodeficiency virus (HIV) related stigma, honor people lost to the disease, and reaffirm the commitment to ensuring HIV is no longer a public health threat. … Continue reading CIRM Joins World AIDS Day Campaign, Commits $104 Million for HIV Research
Empowering Diversity, Equity, and Inclusion: A Week at the SACNAS National Diversity in STEM Conference
When I joined the California Institute for Regenerative Medicine (CIRM) as the new Community Outreach Manager, I was drawn to the Agency’s dedication to diversity, equity, and inclusion (DEI). Some DEI achievements include: Requiring plans for inclusion of diverse or underserved demographic groups in CIRM-funded clinical trials Providing valuable educational opportunities in regenerative medicine for … Continue reading Empowering Diversity, Equity, and Inclusion: A Week at the SACNAS National Diversity in STEM Conference
The Stem Cellar 